News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Numinus Announces Key Milestones in MAPS-Sponsored MDMA-Assisted Therapy for PTSD Clinical Trial
Numinus
Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
Algernon Pharmaceuticals
Enveric Biosciences CEO, Dr. Joseph Tucker, Provides 2021 Year in Review and 2022 Outlook in Letter to Shareholders
Enveric Biosciences
Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent
Optimi Health
Psyched Wellness Announces Vantage Hemp Co. as Contract Manufacturing Organization Partner to Bring AME-1-derived Products to Market
Psyched Wellness
Novamind Closes Arizona Acquisition
Novamind Inc.
Mydecine Signs LOI with The Newly Institute to Provide Psychedelic-Assisted Psychotherapy to Patients under Health Canada's Special Access Program
Mydecine Innovations Group
MindMed Enrolls First Participant in a Study of its Session Monitoring System
Mind Medicine (MindMed)
PharmAla Biotech initiates research at the University of Arkansas for Medical Sciences
Pharmala Biotech Holdings
Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs
Revive Therapeutics
Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder
MindBio Therapeutics
Ketamine One Becomes Exclusive Ketamine Treatment Provider To Victoria Wellness
Wellbeing Digital Sciences
Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product
Numinus
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.